Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4

J Allergy Clin Immunol. 2016 Jan;137(1):327-330. doi: 10.1016/j.jaci.2015.08.036. Epub 2015 Oct 21.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept / therapeutic use*
  • Adolescent
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / genetics*
  • CTLA-4 Antigen / genetics*
  • Female
  • Genetic Variation
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Mutation

Substances

  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Immunosuppressive Agents
  • Abatacept